CogState Stock

CogState Debt

The Debt of CogState (CGS.AX) as of Sep 3, 2026 is 469,900.00 USD. In the previous year, Debt was 672,700.00 USD — a change of -30.15% (lower).

Debt

469,900.00USD

YoY

-30.15%

Last updated:

In 2026, CogState's total debt was 469,900.00 USD, a -30.15% change from the 672,700.00 USD total debt recorded in the previous year.

The CogState Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
81,400.00 USD
Jan 1, 2019
505,000.00 USD
Jan 1, 2020
5.05 M USD
Jan 1, 2021
1.74 M USD
Jan 1, 2022
1.41 M USD
Jan 1, 2023
378,900.00 USD
Jan 1, 2024
672,700.00 USD
Jan 1, 2025
469,900.00 USD
The CogState Debt history
YEARDebtYoY
469,900.00USD-30.15%
672,700.00USD+77.54%
378,900.00USD-73.16%
1.41 MUSD-18.88%
1.74 MUSD-65.55%
5.05 MUSD+900.46%
505,000.00USD+520.39%
81,400.00USD
0.00USD
0.00USD
0.00USD
0.00USD
Access this data via the Eulerpool API

CogState Stock analysis

What does CogState do? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState is one of the most popular companies on Eulerpool.

Debt Details

Understanding CogState's Debt Structure

CogState's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing CogState's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to CogState’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in CogState’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about CogState stock

Debt of CogState is 469,900.00 USD in 2026.

Debt of CogState changed from 672,700.00 USD to 469,900.00 USD, representing a -30.15% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt CogState since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's CogState historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — CogState

All Key Metrics — CogState